Source: International Congress 2015 – Neonatal and paediatric intensive care
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Xueyu Chen (Leiden, Netherlands), Xueyu Chen, Frans Walther, Ruben Van Boxtel, El Houari Laghmani, Rozemarijn Sengers, Gert Folkerts, Edwin Cuppen, Gerry Wagenaar. Deficiency or inhibition of lysophosphatidic acid receptor 1 protects against hyperoxia-induced lung injury in neonatal rats. Eur Respir J 2015; 46: Suppl. 59, 1866

Member's Comments

No comment yet.

Related content which might interest you: Acute protective effect of estradiol on lung inflammation induced by an intestinal ischemic insult in male rats Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 LATE-BREAKING ABSTRACT: Anti-inflammatory effects of diphenyleneiodonium in lipopolysaccharide-induced acute lung injury in rats Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning Year: 2015 CHI-91040, a novel inhaled p38α inhibitor, counteracts lung inflammation induced by IL-1β in the rat Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Proton-sensing TDAG8 exhibits the protective role in lipopolysaccharide-induced acute lung injury Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair Year: 2016 The role of the lysophosphatidic acid (LPA) receptor 1 in developmental alveolarization Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 Anti-inflammatory activity of the bradykinin B1R antagonist in a model of LPS-induced lung inflammation in cynomolgus monkey Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Arginase 1 contributes to fibrogenesis in the lungs of silica-challenge mice Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 A transient receptor potential melastin-2 deficiency significantly worsens the fibrotic response to bleomycin in mice Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Acid sphingomyelinase deficiency improves lung function in allergen-induced asthma in mice Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice via decreasing MCP-1 mRNA Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Targeting the hedgehog/GLI pathway decreases bleomycin-induced lung fibrosis Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 Rho-kinase inhibitor ameliorates bleomycin-induced chronic lung injury in neonatal rats Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care Year: 2011 Thymosin beta4 protects mice from bleomycin-induced damage in the lung Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Infliximab, an anti-tumor necrosis factor-α attenuates bleomycin-induced pulmonary fibrosis in rats Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Chrysin reduces the degree of lung injure which induced by lipopolysaccharides (LPS): Possible involvement of oxidative stress and the NF-κB pathway Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 Chronic intermittent hypoxia induces liver injury in mice with diet induced obesity via TLR4/MyD88/MAPK/NF-kB signaling pathways Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016 Effects of a highly selective CXCR3 antagonist in two murine models of lung inflammation Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1 Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 Galectin-9 attenuates elastase-induced emphysema by reducing neutrophil chemotaxis in mice Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Effect of MSC treatment on LPS-induced inflammation, emphysema and atherosclerosis in E3L mice Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015